サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1611199

DNA診断の市場規模、シェア、動向分析レポート：技術別、用途別、地域別、セグメント予測、2025年～2030年

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis), By Application (Cancer Genetics Tests, Infectious Diseases DNA Testing), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
DNA診断の市場規模、シェア、動向分析レポート：技術別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年11月22日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

DNA診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のDNA診断市場規模は2030年に141億4,000万米ドルに達し、2025～2030年にかけてCAGR 8.7％で成長すると予測されています。

同市場の成長は、ゲノムシークエンシングの進歩と個別化DNAレベル診断アプリケーションの開発によるものです。さらに、政府が後援する特許研究イニシアティブや資金提供プロジェクトの増加が、市場の需要をさらに促進すると予測されています。例えば、2022年12月に英国政府は、先進的なゲノム研究の開発と創出のために2億2,940万米ドル（1億7,500万円）の資金提供を発表しました。

市場の成長は、ゲノムプロファイリングのための新規技術の採用よって大きく促進されます。さらに、個別化医療による治療や診断のためにDNAプロトタイピングに依存する慢性腫瘍や感染症の罹患率の増加に伴い、DNA診断/検査による研究の需要は予測期間中に大幅に増加すると予想されます。さらに、DNA診断/検査に対する需要の増加は、出生前検査や体外受精に対する需要の高まりに牽引されており、市場にポジティブな成長展望をもたらすと予想されます。2022年9月、Eurofins Genomaは胚を含まない非侵襲的着床前スクリーニング検査であるniPGT-Aの発売を発表しました。

DNA診断は、次世代シーケンシング（NGS）などの技術により腫瘍ゲノムの包括的分析を可能にします。NGSでは複数の遺伝子の同時シーケンスが可能であり、腫瘍に存在する遺伝子変化の詳細なビューを記載しています。腫瘍ゲノムを正常組織DNAと比較することで、科学者や臨床医は、がん細胞に特有の変異、コピー数の変動、構造再配列を特定することができます。2022年6月、DNAシーケンスとアレイベースの技術プロバイダーであるイルミナは、腫瘍ゲノムに関するより深い洞察を解き明かすことを目的として、Merckと共同で開発した研究テストを発表します。

C型肝炎ウイルス（HCV）は世界の健康問題であり、世界中で数百万人が罹患しています。HCVを正確かつタイムリーに診断することは、効果的な治療とさらなるトランスミッションの予防に不可欠です。このような状況において、DNA診断薬はHCV感染を検出・管理するための強力なツールとして浮上してきました。2022年7月、ロシュはC型肝炎ウイルス撲滅に向けた世界の取り組みを支援するため、画期的な抗原・抗体二重診断検査Elecsys HCV Duoを発表しました。

DNA診断薬市場レポートハイライト

  • PCRベースの診断セグメントは2024年に49.40%の最大シェアを占めました。このセグメントの優位性は、革新的なPCRベースの診断薬を導入する主要企業が増加したことにより、市場で広く使用され、製品の入手可能性が高まったことに起因します。
  • NGS DNA診断は、包括的な遺伝子分析を可能にする高性能シーケンス技術の進歩により、予測期間中に13.9%のCAGRで急成長すると予測されています。
  • がん遺伝子検査セグメントは2024年に29.80%の最大シェアを占めました。DNAシーケンシング技術は、さまざまながん種や遺伝性疾患の同定と特徴づけにますます利用されるようになっています。
  • 北米DNA診断市場は世界市場全体を支配し、2024年には42.72％の売上シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 DNA診断市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • DNA診断市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 DNA診断市場：技術別、推定・動向分析

  • セグメントダッシュボード
  • DNA診断市場：技術変動分析
  • 技術展望によるDNA診断市場
  • 2018～2030年の市場規模と予測と動向分析
  • PCRベースの診断
  • NGS DNA診断
  • in situハイブリダイゼーション診断
  • マイクロアレイベースの診断
  • その他

第5章 DNA診断市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • DNA診断市場：用途変動分析
  • DNA診断市場の用途別展望
  • 2018～2030年の市場規模と予測と動向分析
  • がん遺伝子検査
  • 感染症DNA検査
    • HBV診断
    • 結核診断
    • CT/NG診断
    • HPV診断
    • MRSA診断
    • その他
  • 新生児遺伝子スクリーニング
  • 着床前診断と生殖診断
  • 非感染性疾患のDNA検査
    • 心血管疾患
    • CNSとPNS関連
    • 骨格、結合組織、外胚葉、真皮のDNA検査
    • 肺、腎臓、肝臓、消化器関連
    • 感覚疾患
  • 出生前DNAキャリアスクリーニング
  • 薬理ゲノム学/薬剤代謝
  • 血液学と免疫学/身元診断と法医学
  • その他

第6章 DNA診断市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • 地域DNA診断市場変動分析
  • DNA診断市場：技術、生体材料、最終用途による地域推定・動向分析
  • 2018～2030年の市場規模と予測と動向分析
  • 北米
    • 米国
    • カナダ
    • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • ノルウェー
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • アルゼンチン
    • メキシコ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 市場参入企業の分類
  • 企業分類
  • 戦略マッピング
    • 新製品発売
    • パートナーシップ
    • 取得
    • コラボレーション
  • 主要企業の市場シェア分析、2024年
  • 主要企業プロファイル
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Hologic, Inc.
    • Agilent Technologies Inc.
    • Siemens Healthineers AG
    • Danaher Corporation
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4. Global DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America DNA diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6. North America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 7. North America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8. U.S. DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 9. U.S. DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 10. Canada DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 11. Canada DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 12. Mexico DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 13. Mexico DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14. Europe DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16. Europe DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 17. UK DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18. UK DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19. Germany DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20. Germany DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 21. France DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22. France DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 23. Italy DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24. Italy DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 25. Spain DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 26. Spain DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27. Denmark DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28. Denmark DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 29. Norway DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 30. Norway DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 31. Sweden DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32. Sweden DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36. Japan DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 37. Japan DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 38. China DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39. China DNA diagnostics market, by application 2018 - 2030 (USD Million)
  • Table 40. India DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 41. India DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 42. Australia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Australia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44. South Korea DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45. South Korea DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 46. Thailand DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47. Thailand DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48. Latin America DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50. Latin America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 51. Brazil DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52. Brazil DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 53. Argentina DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54. Argentina DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa DNA diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 58. South Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59. South Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 62. UAE DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63. UAE DNA diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 64. Kuwait DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65. Kuwait DNA diagnostics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 DNA diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology snapshot
  • Fig. 10 Application snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market value, 2024 (USD Million)
  • Fig. 13 Market dynamics
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 DNA diagnostics market: Technology outlook and key takeaways
  • Fig. 17 DNA diagnostics market: Technology movement analysis
  • Fig. 18 PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Microarrays-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 In-situ hybridization diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 NGS DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 DNA diagnostics market: Application outlook and key takeaways
  • Fig. 24 DNA diagnostics market: Application movement analysis
  • Fig. 25 Cancer genetics tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 HBV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 TB diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 CT/NG diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 HPV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 MRSA diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Preimplantation & reproductive diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Non-infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Cardiovascular diseases diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 CNS & PNS related market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Skeletal, connective, ectodermal & dermal DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Lung, kidney, liver & GT related market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Sensory diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Prenatal DNA carrier screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmacogenomics/drug metabolism market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hematology & immunology/identity diagnostics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 DNA diagnostics market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 U.S. DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Canada DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Mexico DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Germany DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 France DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Rest of Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Japan DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 China DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 China regulatory details
  • Fig. 79 Key country dynamics
  • Fig. 80 India DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 South Korean regulations in four hierarchical orders
  • Fig. 88 Rest of Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Brazil DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Argentina DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Rest of Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Africa DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 UAE DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Kuwait DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Rest of MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key company categorization
  • Fig. 106 Heat map analysis
  • Fig. 107 Strategic framework
目次
Product Code: 978-1-68038-676-9

DNA Diagnostics Market Growth & Trends:

The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion in 2030 and is projected to grow at a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights:

  • The PCR-based diagnostics segment held the largest share of 49.40% in 2024, the dominance of this segment can be attributed to the widespread market usage and the increase in product availability due to the rising number of key players introducing innovative PCR-based diagnostics
  • NGS DNA diagnosis is projected to grow fastest CAGR of 13.9% over the forecast period owing to advancements in high-throughput sequencing technologies that enable comprehensive genetic analyses.
  • Cancer genetics tests segment held the largest share of 29.80% in 2024. DNA sequencing technologies are increasingly utilized to identify and characterize various cancer types and genetic disorders.
  • North America DNA diagnostics market dominated the overall global market and accounted for the 42.72% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. DNA Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. DNA Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. DNA Diagnostics Market: Technology Movement Analysis
  • 4.3. DNA Diagnostics Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. PCR-based Diagnostics
    • 4.5.1. PCR-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. NGS DNA Diagnosis
    • 4.6.1. NGS DNA Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. In-Situ Hybridization Diagnostics
    • 4.7.1. In-Situ Hybridization Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Microarrays-based Diagnostics
    • 4.8.1. Microarrays-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Other Technologies
    • 4.9.1. In Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. DNA Diagnostics Market: Application Movement Analysis
  • 5.3. DNA Diagnostics Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Cancer Genetics Tests
    • 5.5.1. Cancer Genetics Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Infectious Diseases DNA Testing
    • 5.6.1. Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. HBV Diagnostic
      • 5.6.2.1. HBV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. TB Diagnostic
      • 5.6.3.1. TB Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. CT/NG Diagnostic
      • 5.6.4.1. CT/NG Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. HPV Diagnostic
      • 5.6.5.1. HPV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. MRSA Diagnostic
      • 5.6.6.1. MRSA Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Others
      • 5.6.7.1. Others Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Newborn Genetic Screening
    • 5.7.1. Newborn Genetic Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Preimplantation & Reproductive Diagnosis
    • 5.8.1. Preimplantation & Reproductive Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Non-Infectious Diseases DNA Testing
    • 5.9.1. Non-Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Cardiovascular Diseases
      • 5.9.2.1. Cardiovascular Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. CNS & PNS Related
      • 5.9.3.1. CNS & PNS Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing
      • 5.9.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.5. Lung, Kidney, Liver & GT Related
      • 5.9.5.1. Lung, Kidney, Liver & GT Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.6. Sensory Diseases
      • 5.9.6.1. Sensory Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Prenatal DNA Carrier Screening
    • 5.10.1. Prenatal DNA Carrier Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Pharmacogenomics/Drug Metabolism
    • 5.11.1. Pharmacogenomics/Drug Metabolism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Hematology & Immunology/Identity Diagnostics & Forensics
    • 5.12.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.13. Others
    • 5.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. DNA Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional DNA Diagnostics Market movement analysis
  • 6.3. DNA Diagnostics Market: Regional Estimates & Trend Analysis by Technology, Biomaterial & End-use
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Competitive Scenario
    • 6.5.3. Canada
      • 6.5.3.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Competitive Scenario
    • 6.5.4. Europe
    • 6.5.5. Europe DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. UK
      • 6.5.6.1. UK DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.6.2. Key Country Dynamics
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Scenario
      • 6.5.6.5. Competitive Scenario
    • 6.5.7. Germany
      • 6.5.7.1. Germany DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.7.2. Key Country Dynamics
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Scenario
      • 6.5.7.5. Competitive Scenario
    • 6.5.8. France
      • 6.5.8.1. France DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.8.2. Key Country Dynamics
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Scenario
      • 6.5.8.5. Competitive Scenario
    • 6.5.9. Italy
      • 6.5.9.1. Italy DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.9.2. Key Country Dynamics
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Scenario
      • 6.5.9.5. Competitive Scenario
    • 6.5.10. Spain
      • 6.5.10.1. Spain DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.10.2. Key Country Dynamics
      • 6.5.10.3. Regulatory Framework
      • 6.5.10.4. Reimbursement Scenario
      • 6.5.10.5. Competitive Scenario
    • 6.5.11. Denmark
      • 6.5.11.1. Denmark DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.11.2. Key Country Dynamics
      • 6.5.11.3. Regulatory Framework
      • 6.5.11.4. Reimbursement Scenario
      • 6.5.11.5. Competitive Scenario
    • 6.5.12. Norway
      • 6.5.12.1. Norway DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.12.2. Key Country Dynamics
      • 6.5.12.3. Regulatory Framework
      • 6.5.12.4. Reimbursement Scenario
      • 6.5.12.5. Competitive Scenario
    • 6.5.13. Sweden
      • 6.5.13.1. Sweden DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.13.2. Key Country Dynamics
      • 6.5.13.3. Regulatory Framework
      • 6.5.13.4. Reimbursement Scenario
      • 6.5.13.5. Competitive Scenario
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Japan DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Competitive Scenario
    • 6.6.3. China
      • 6.6.3.1. China DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Competitive Scenario
    • 6.6.4. India
      • 6.6.4.1. India DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. Competitive Scenario
    • 6.6.5. South Korea
      • 6.6.5.1. South Korea DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Competitive Scenario
    • 6.6.6. Australia
      • 6.6.6.1. Australia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.6.2. Key Country Dynamics
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Scenario
      • 6.6.6.5. Competitive Scenario
    • 6.6.7. Thailand
      • 6.6.7.1. Thailand DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.7.2. Key Country Dynamics
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Scenario
      • 6.6.7.5. Competitive Scenario
  • 6.7. Latin America
    • 6.7.1. Latin America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.2.1. Brazil DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.2.2. Key Country Dynamics
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Scenario
      • 6.7.2.5. Competitive Scenario
    • 6.7.3. Argentina
      • 6.7.3.1. Argentina DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.3.2. Key Country Dynamics
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Scenario
      • 6.7.3.5. Competitive Scenario
    • 6.7.4. Mexico
      • 6.7.4.1. Mexico DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.4.2. Key Country Dynamics
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement Scenario
      • 6.7.4.5. Competitive Scenario
  • 6.8. Middle East & Africa
    • 6.8.1. Middle East & Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. South Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.2.2. Key Country Dynamics
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Scenario
      • 6.8.2.5. Competitive Scenario
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Saudi Arabia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.3.2. Key Country Dynamics
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Scenario
      • 6.8.3.5. Competitive Scenario
    • 6.8.4. UAE
      • 6.8.4.1. UAE DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.4.2. Key Country Dynamics
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Scenario
      • 6.8.4.5. Competitive Scenario
    • 6.8.5. Kuwait
      • 6.8.5.1. Kuwait DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.8.5.2. Key Country Dynamics
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Scenario
      • 6.8.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Categorization
  • 7.3. Strategy Mapping
    • 7.3.1. NEW PRODUCT LAUNCH
    • 7.3.2. PARTNERSHIPS
    • 7.3.3. ACQUISITION
    • 7.3.4. COLLABORATION
  • 7.4. Key Company Market Share Analysis, 2024
  • 7.5. Key Company Profiles
    • 7.5.1. Abbott
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Technology benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. F. Hoffmann-La Roche Ltd.
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Technology benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. QIAGEN
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Technology benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Bio-Rad Laboratories, Inc.
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Technology benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Thermo Fisher Scientific, Inc.
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Technology benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Illumina, Inc.
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Technology benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Hologic, Inc.
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Technology benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Agilent Technologies Inc.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Technology benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Siemens Healthineers AG
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Technology benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Danaher Corporation
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Technology benchmarking
      • 7.5.10.4. Strategic initiatives